Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study.

[1]  M. Selman,et al.  72-kD (MMP-2) and 92-kD (MMP-9) Type IV Collagenase Production and Activity in Different Histologic Types of Lung Cancer Cells , 1998, Pathobiology.

[2]  K. Yasumoto,et al.  Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung , 1997, Pathology international.

[3]  A. Fraire,et al.  Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful? , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[4]  K. Inoue,et al.  Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer , 1994, Cancer.

[5]  J. Nesland,et al.  Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma , 1994, Cancer.

[6]  K. Shirouzu,et al.  [Matrix metalloproteinase 9 (92kDa gelatinase/type IV collagenase) is implicated in liver metastasis in colorectal cancers: preliminary report]. , 1993, Nihon Geka Gakkai zasshi.

[7]  K. Takishima,et al.  Immunohistochemical Analysis of Cathepsin B Expression in Human Lung Adenocarcinoma: The Role in Cancer Progression , 1993, Japanese journal of cancer research : Gann.

[8]  T. Hirano,et al.  Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastasis. , 1993, Cancer letters.

[9]  J. Carmichael,et al.  Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. , 1993, Journal of the National Cancer Institute.

[10]  M. Higashiyama,et al.  Cathepsin B expression in tumour cells and laminin distribution in pulmonary adenocarcinoma. , 1993, Journal of clinical pathology.

[11]  H. Nagase,et al.  Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1 beta and a protein kinase C activator. , 1992, Experimental cell research.

[12]  K. Inada,et al.  Development of Liver Metastasis in Colorectal Carcinoma , 1991, Acta pathologica japonica.

[13]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[14]  Bonnie F. Sloane,et al.  Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors. , 1990, Cancer research.

[15]  K. Sheahan,et al.  Cysteine protease activities and tumor development in human colorectal carcinoma. , 1989, Cancer research.

[16]  Bonnie F. Sloane,et al.  Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. , 1987, Cancer research.

[17]  H. Kleinman,et al.  Regulation of cell attachment and cell number by fibronectin and laminin , 1986, Journal of cellular physiology.

[18]  Bonnie F. Sloane,et al.  Cathepsin B: association with plasma membrane in metastatic tumors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Bonnie F. Sloane,et al.  Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. , 1982, Cancer research.

[20]  A. Poole,et al.  Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas , 1978, Nature.

[21]  U. Moll,et al.  Mr 92,000 Type IV Collagenase Is Increased in Plasma of Patients with Colon Cancer and Breast Cancer , 1993 .

[22]  L. Matrisian.  Metalloproteinases and their inhibitors in matrix remodeling. , 1990, Trends in genetics : TIG.

[23]  L. Liotta.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.